Aperam S.A.
APEMY · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.09 | -0.13 | 0.13 | -0.41 |
| FCF Yield | 8.55% | 7.75% | -7.12% | 7.92% |
| EV / EBITDA | 37.41 | 30.44 | 69.39 | 20.13 |
| Quality | ||||
| ROIC | 0.23% | 0.64% | -0.11% | 0.30% |
| Gross Margin | 85.58% | 100.00% | 100.00% | 100.00% |
| Cash Conversion Ratio | 21.31 | 4.17 | 9.55 | 2.69 |
| Growth | ||||
| Revenue 3-Year CAGR | -1.15% | -3.63% | -6.96% | -8.47% |
| Free Cash Flow Growth | 9.29% | 198.74% | -209.66% | 1,511.11% |
| Safety | ||||
| Net Debt / EBITDA | 14.20 | 12.35 | 24.70 | 4.61 |
| Interest Coverage | 0.32 | 2.18 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 47.65 | 0.00 | 20.92 |